SurgePays (SURG) Competitors $1.82 +0.04 (+1.96%) (As of 03:34 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends SURG vs. SRTS, TLSI, ZJYL, TELA, GUTS, FONR, MGRM, ECOR, LNSR, and EDAPShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Sensus Healthcare (SRTS), TriSalus Life Sciences (TLSI), Jin Medical International (ZJYL), TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), Monogram Orthopaedics (MGRM), electroCore (ECOR), LENSAR (LNSR), and Edap Tms (EDAP). These companies are all part of the "medical equipment" industry. SurgePays vs. Sensus Healthcare TriSalus Life Sciences Jin Medical International TELA Bio Fractyl Health FONAR Monogram Orthopaedics electroCore LENSAR Edap Tms SurgePays (NASDAQ:SURG) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends, media sentiment and community ranking. Does the MarketBeat Community prefer SURG or SRTS? Sensus Healthcare received 12 more outperform votes than SurgePays when rated by MarketBeat users. However, 69.11% of users gave SurgePays an outperform vote while only 68.42% of users gave Sensus Healthcare an outperform vote. CompanyUnderperformOutperformSurgePaysOutperform Votes17069.11% Underperform Votes7630.89% Sensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% Is SURG or SRTS more profitable? Sensus Healthcare has a net margin of 22.54% compared to SurgePays' net margin of -27.39%. Sensus Healthcare's return on equity of 17.99% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets SurgePays-27.39% -55.63% -43.61% Sensus Healthcare 22.54%17.99%16.26% Which has more volatility and risk, SURG or SRTS? SurgePays has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Do analysts prefer SURG or SRTS? SurgePays currently has a consensus price target of $8.50, suggesting a potential upside of 371.93%. Sensus Healthcare has a consensus price target of $12.50, suggesting a potential upside of 60.67%. Given SurgePays' higher probable upside, research analysts clearly believe SurgePays is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SurgePays 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media favor SURG or SRTS? In the previous week, SurgePays had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 3 mentions for SurgePays and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.33 beat SurgePays' score of 0.10 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SurgePays 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of SURG or SRTS? 6.9% of SurgePays shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 29.4% of SurgePays shares are owned by company insiders. Comparatively, 9.4% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation and earnings, SURG or SRTS? SurgePays has higher revenue and earnings than Sensus Healthcare. SurgePays is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgePays$137.14M0.26$20.62M-$1.13-1.59Sensus Healthcare$41.31M3.09$490K$0.5713.65 SummarySensus Healthcare beats SurgePays on 13 of the 19 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ ExchangeMarket Cap$36.31M$21.59B$24.68B$9.28BDividend YieldN/A3.77%2.69%4.06%P/E Ratio-1.5917.78276.4417.51Price / Sales0.263.672,918.93142.21Price / Cash1.398.5033.7437.95Price / Book1.072.657.904.94Net Income$20.62M$770.69M$658.53M$225.59M7 Day Performance-2.64%-1.58%0.25%-1.07%1 Month Performance16.20%-1.07%10.62%7.23%1 Year Performance-66.21%6.13%27.10%22.97% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays2.9186 of 5 stars$1.83+2.0%$8.50+365.8%-66.5%$36.79M$137.14M-1.6222Analyst ForecastSRTSSensus Healthcare4.1788 of 5 stars$8.00-2.0%$12.50+56.3%+224.2%$131.12M$24.41M14.3240Positive NewsTLSITriSalus Life Sciences4.0874 of 5 stars$3.95+1.0%$12.08+205.9%-54.9%$120.45M$26.89M-1.57106Analyst ForecastNews CoveragePositive NewsGap UpZJYLJin Medical InternationalN/A$0.77-0.4%N/A-97.4%$120.11M$19.82M0.00245TELATELA Bio3.1038 of 5 stars$2.85+2.9%$9.25+224.6%-52.1%$112.26M$58.45M-1.64120GUTSFractyl Health1.2145 of 5 stars$2.11+3.4%$22.00+942.7%N/A$101.49M$120,000.00-0.17102News CoverageFONRFONAR1.2703 of 5 stars$15.38-1.0%N/A-23.7%$97.33M$102.01M11.09480MGRMMonogram Orthopaedics3.6758 of 5 stars$2.78+4.5%$4.00+43.9%-22.6%$95.39M$364,999.00-5.6628News CoverageECORelectroCore2.5469 of 5 stars$14.12+3.7%N/A+161.8%$92.56M$23.33M-7.4450Analyst ForecastNews CoverageGap UpLNSRLENSAR0.7769 of 5 stars$7.45-1.3%$8.00+7.4%+238.6%$86.53M$48.87M-5.17110EDAPEdap Tms3.4328 of 5 stars$2.24+1.8%$19.00+748.2%-52.1%$83.11M$63.41M-3.38307Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies Sensus Healthcare Competitors TriSalus Life Sciences Competitors Jin Medical International Competitors TELA Bio Competitors Fractyl Health Competitors FONAR Competitors Monogram Orthopaedics Competitors electroCore Competitors LENSAR Competitors Edap Tms Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SURG) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURG Stock Alerts